Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 76INDUSTRY 10OTHER_GOV 3NIH 3NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 1Breast 1

Conditions

Cancer Pain 2Wounds and Injuries 1Head and Neck Neoplasms 1Breast Neoplasms 1Breakthrough Pain 1Agnosia 1

Interventions

Cisplatin 50Capecitabine 42apatinib 34Radiotherapy 33Oxaliplatin 33Gemcitabine 33Cyclophosphamide 32Drug Therapy 31Paclitaxel 30Carboplatin 29tislelizumab 27Irinotecan 27Fluorouracil 26Docetaxel 26Bevacizumab 23Surgical Procedures, Operative 21Nivolumab 19pembrolizumab 18fludarabine 18Radiation 16Metformin 16Exercise 16camrelizumab 15S 1 (combination) 14Control Groups 14Blood Specimen Collection 14Pemetrexed 13Standard of Care 12anlotinib 11Neoadjuvant Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Morphine × Clear all
NCT05800834 2023-09-28

MorphineGEL

Instituto Nacional de Cancer, Brazil

Phase 2 Unknown
106 enrolled
BreastHead & Neck

Cancer Pain, Breast Neoplasms, Head and Neck Neoplasms, Wounds and Injuries

NCT05037539 2022-08-31

Efficacy of Injectable Fentanyl in Sublingual Route Versus Oral Morphine Syrup for Breakthrough Pain

Department of Medical Services Ministry of Public Health of Thailand

Phase 1/2 Completed
20 enrolled

Breakthrough Pain

NCT04243954 2021-03-05

Intravenous vs Oral Analgesia in Cancer Patients With Severe Pain After Successful Titration

Fujian Cancer Hospital

Phase 2 Completed
95 enrolled

Cancer Pain, Agnosia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡